Although CRISPR–Cas first made a splash in gene editing, scientists now use it to precisely target epigenetic editors to any DNA sequence. Nature reports on companies exploring epigenetic-editing technology and a handful of early-stage clinical trials. 🧬🧪
Epigenetic editing makes its markResearchers are rewriting the chemical tags on DNA and chromatin to tune gene expression.go.nature.com